XML 44 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation (Tables)
3 Months Ended
Jul. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

 Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

   Three months ended July 31, 
   2021   2020 
Risk-free interest rate   1.0%   N/A 
Expected dividend yield   0.0%   N/A 
Expected life (in years)   5.8%   N/A 
Expected volatility   120.0%   N/A 
Schedule of Stock Option Activity

A summary of stock options under our stock incentive plans is detailed in the following table.

 

            Weighted 
            Average 
        Weighted   Remaining 
    Shares   Average   Contractual 
    Underlying   Exercise   Term 
    Options   Price   (In Years) 
Outstanding as of April 30, 2021    516,827   $3.89    8.3 
Granted    -   $-      
Exercised    -   $-      
Cancelled/forfeited    (3,681)  $13.81      
Outstanding as of July 31, 2021    513,146   $3.81    8.7 
Exercisable as of July 31, 2021    247,954   $4.92    8.0 
Schedule of Business Acquisition and Fair Value of Net Assets, Compensation Expense Recognized

 

Fair Value of Purchase  $1,161,267 
Total Acquired Assets  $(593,571) 
Total Acquired Liabilities  $117,106
Compensation Expense  $684,802 
Quarterly Compensation Expense  $171,201 
Schedule of Non-vested Restricted Stock Activity

A summary of non-vested restricted stock under our stock incentive plans is as follows:

 

       Weighted 
   Number   Average Price per 
   of Shares   Share 
Issued and unvested at April 30, 2021   10,000   $2.93 
Granted   100,000   $2.37 
Vested   -   $- 
Cancelled/forfeited   -   $- 
Issued and unvested at July 31, 2021   110,000   $2.42 
Performance Stock Options [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The Company determined these awards contain a market- based condition and estimated the fair value using the Monte Carlo simulation model with the following assumptions:

 Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

   Three months ended January 31, 
   2021   2020 
Risk-free interest rate   1.0%   N/A 
Expected dividend yield   0.0%   N/A 
Expected life (in years)   5.8    N/A 
Expected volatility   120.0%   N/A 
Schedule of Stock Option Activity

A summary of performance stock options under our stock incentive plans is detailed in the following table.

 

            Weighted 
            Average 
        Weighted   Remaining 
    Shares   Average   Contractual 
    Underlying   Exercise   Term 
    Options   Price   (In Years) 
Outstanding as of April 30, 2021    424,790   $2.57    8.7 
Granted    -   $-      
Exercised    -   $-      
Cancelled/forfeited    (6,767)  $2.93      
Outstanding as of July 31, 2021    418,023   $2.56    9.3 
Exercisable as of July 31, 2021    40,668   $1.05    8.5